<?xml version="1.0" encoding="UTF-8"?>
<p id="p0245">Another compound exhibiting strong antiviral activity is FV-100. This compound has a high selectivity for VZV. Unfortunately, its activity was not observed in comparative studies of other herpesviruses (
 <xref rid="bib63" ref-type="bibr">Mcguigan et al., 2007</xref>). This drug was tested in a phase 2 clinical trial in comparison with valaciclovir for herpes zoster (NCT00900783) and in a phase 3 clinical trial in comparison with valaciclovir for the prevention of post-herpetic neuralgia (NCT02412917).
</p>
